Initially there was no specific way to reverse uh like so um you know I mean you know like um okay reverse reverse reverse reverse reverse reverse reverse reverse reverse reverse so okay okay so I mean okay I mean well you know okay the anticoagulant effect of dabigatran in the event of of of so I mean so you know you know I mean um I mean you know well of of of of of of of of a uh well well well so you know um um okay okay major bleeding event, unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.